Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021:180:85-117.
doi: 10.1007/112_2021_60.

When Glycosylation Meets Blood Cells: A Glance of the Aberrant Glycosylation in Hematological Malignancies

Huining Su  1 , Mimi Wang  1 , Xingchen Pang  2 , Feng Guan  2 , Xiang Li  3 , Ying Cheng  4
Affiliations
Review

When Glycosylation Meets Blood Cells: A Glance of the Aberrant Glycosylation in Hematological Malignancies

Huining Su et al. Rev Physiol Biochem Pharmacol. 2021.

Abstract

Among neoplasia-associated epigenetic alterations, changes in cellular glycosylation have recently received attention as a key component of hematological malignancy progression. Alterations in glycosylation appear to not only directly impact cell growth and survival, but also alter the adhesion of tumor cells and their interactions with the microenvironment, facilitating cancer-induced immunomodulation and eventual metastasis. Changes in glycosylation arise from altered expression of glycosyltransferases, enzymes that catalyze the transfer of saccharide moieties to a wide range of acceptor substrates, such as proteins, lipids, and other saccharides in the endoplasmic reticulum (ER) and Golgi apparatus. Novel glycan structures in hematological malignancies represent new targets for the diagnosis and treatment of blood diseases. This review summarizes studies of the aberrant expression of glycans commonly found in hematological malignancies and their potential mechanisms and defines the specific roles of glycans as drivers or passengers in the development of hematological malignancies.

Keywords: Glycans; Glycosyltransferase; Hematological malignancies; Lectin; N-glycosylation; O-glycosylation.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Abroun S, Otsuyama K, Shamsasenjan K, Islam A, Amin J, Iqbal MS, Gondo T, Asaoku H, Kawano MM (2008) Galectin-1 supports the survival of CD45RA(−) primary myeloma cells in vitro. Br J Haematol 142(5):754–765 - PubMed - DOI
    1. Aller CT, Kucuk O, Springer GF, Gilman-Sachs A (1996) Flow cytometric analysis of T and Tn epitopes on chronic lymphocytic leukemia cells. Am J Hematol 52(1):29–38 - PubMed - DOI
    1. Almeida AM, Ramos F (2016) Acute myeloid leukemia in the older adults. Leuk Res Rep 6:1–7 - PubMed - PMC
    1. Amin R, Mourcin F, Uhel F, Pangault C, Ruminy P, Dupre L, Guirriec M, Marchand T, Fest T, Lamy T, Tarte K (2015) DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma. Blood 126(16):1911–1920 - PubMed - PMC - DOI
    1. Araki M, Yang Y, Masubuchi N, Hironaka Y, Takei H, Morishita S, Mizukami Y, Kan S, Shirane S, Edahiro Y, Sunami Y, Ohsaka A, Komatsu N (2016) Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms. Blood 127(10):1307–1316 - PubMed - DOI

LinkOut - more resources